Derek A Cummings,
Professor; EPI Associate Director For Education And Graduate Programs
Teaching Profile
Courses Taught
2017-2023
ZOO4926 Special Topics in Zoology
2018
FOR7980 Research for Doctoral Dissertation
2018
ZOO7980 Research for Doctoral Dissertation
2017
BMS4905 Medical Sciences Senior Research
2016
PHC7916 National Field Epidemiology
2016
PHC7979 Advanced Research
2023-2024
PHC6971 Research for Master’s Thesis
Research Profile
Open Researcher and Contributor ID (ORCID)
0000-0002-9437-1907
Publications
2024
Integration of population-level data sources into an individual-level clinical prediction model for dengue virus test positivity
Science Advances.
10(7)
[DOI] 10.1126/sciadv.adj9786.
[PMID] 38363842.
2023
Accounting for assay performance when estimating the temporal dynamics in SARS-CoV-2 seroprevalence in the U.S.
Nature Communications.
14(1)
[DOI] 10.1038/s41467-023-37944-5.
[PMID] 37076502.
2023
Evidence of leaky protection following COVID-19 vaccination and SARS-CoV-2 infection in an incarcerated population
Nature Communications.
14(1)
[DOI] 10.1038/s41467-023-40750-8.
[PMID] 37598213.
2023
Household immunity and individual risk of infection with dengue virus in a prospective, longitudinal cohort study
Nature Microbiology.
9(1):274-283
[DOI] 10.1038/s41564-023-01543-3.
[PMID] 38110699.
2023
Maternally derived antibody titer dynamics and risk of hospitalized infant dengue disease
Proceedings of the National Academy of Sciences.
120(41)
[DOI] 10.1073/pnas.2308221120.
[PMID] 37774093.
2022
Assessing the role of multiple mechanisms increasing the age of dengue cases in Thailand
Proceedings of the National Academy of Sciences.
119(20)
[DOI] 10.1073/pnas.2115790119.
[PMID] 35533273.
2022
Effectiveness of an inactivated Covid-19 vaccine with homologous and heterologous boosters against Omicron in Brazil
Nature Communications.
13(1)
[DOI] 10.1038/s41467-022-33169-0.
[PMID] 36202800.
2022
EVITA Dengue: a cluster-randomized controlled trial to EValuate the efficacy of Wolbachia-InfecTed Aedes aegypti mosquitoes in reducing the incidence of Arboviral infection in Brazil
Trials.
23(1)
[DOI] 10.1186/s13063-022-05997-4.
[PMID] 35236394.
2022
Periodic synchronisation of dengue epidemics in Thailand over the last 5 decades driven by temperature and immunity
PLOS Biology.
20(3)
[DOI] 10.1371/journal.pbio.3001160.
[PMID] 35302985.
2022
Structural factors associated with SARS-CoV-2 infection risk in an urban slum setting in Salvador, Brazil: A cross-sectional survey
PLOS Medicine.
19(9)
[DOI] 10.1371/journal.pmed.1004093.
[PMID] 36074784.
2021
Age-specific mortality and immunity patterns of SARS-CoV-2
Nature.
590(7844):140-145
[DOI] 10.1038/s41586-020-2918-0.
2021
Age-specific social mixing of school-aged children in a US setting using proximity detecting sensors and contact surveys
Scientific Reports.
11(1)
[DOI] 10.1038/s41598-021-81673-y.
[PMID] 33504823.
2021
Antigenic evolution of dengue viruses over 20 years
Science.
374(6570):999-1004
[DOI] 10.1126/science.abk0058.
[PMID] 34793238.
2021
Effect of specific non-pharmaceutical intervention policies on SARS-CoV-2 transmission in the counties of the United States
Nature Communications.
12(1)
[DOI] 10.1038/s41467-021-23865-8.
[PMID] 34117244.
2021
Effectiveness of ChAdOx1 vaccine in older adults during SARS-CoV-2 Gamma variant circulation in São Paulo
Nature Communications.
12(1)
[DOI] 10.1038/s41467-021-26459-6.
[PMID] 34711813.
2021
Evaluation of the extended efficacy of the Dengvaxia vaccine against symptomatic and subclinical dengue infection
Nature Medicine.
27(8):1395-1400
[DOI] 10.1038/s41591-021-01392-9.
[PMID] 34168334.
2021
Influenza and other respiratory viral infections associated with absence from school among schoolchildren in Pittsburgh, Pennsylvania, USA: a cohort study
BMC Infectious Diseases.
21(1)
[DOI] 10.1186/s12879-021-05922-1.
[PMID] 33752625.
2021
Insights into household transmission of SARS-CoV-2 from a population-based serological survey
Nature Communications.
12(1)
[DOI] 10.1038/s41467-021-23733-5.
[PMID] 34131124.
2021
Modelling distributions of Aedes aegypti and Aedes albopictus using climate, host density and interspecies competition
PLOS Neglected Tropical Diseases.
15(3)
[DOI] 10.1371/journal.pntd.0009063.
[PMID] 33764975.
2021
Reconstructing unseen transmission events to infer dengue dynamics from viral sequences
Nature Communications.
12(1)
[DOI] 10.1038/s41467-021-21888-9.
[PMID] 33753725.
2021
Risk Factors for Healthcare Personnel Infection With Endemic Coronaviruses (HKU1, OC43, NL63, 229E): Results from the Respiratory Protection Effectiveness Clinical Trial (ResPECT)
Clinical Infectious Diseases.
73(11):e4428-e4432
[DOI] 10.1093/cid/ciaa900.
[PMID] 32645144.
2021
Trip duration drives shift in travel network structure with implications for the predictability of spatial disease spread
PLOS Computational Biology.
17(8)
[DOI] 10.1371/journal.pcbi.1009127.
[PMID] 34375331.
2020
A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity
Nature Communications.
11(1)
[DOI] 10.1038/s41467-020-18450-4.
[PMID] 32943637.
2020
An open source tool to infer epidemiological and immunological dynamics from serological data: serosolver
PLOS Computational Biology.
16(5)
[DOI] 10.1371/journal.pcbi.1007840.
[PMID] 32365062.
2020
Life course exposures continually shape antibody profiles and risk of seroconversion to influenza
PLOS Pathogens.
16(7)
[DOI] 10.1371/journal.ppat.1008635.
[PMID] 32702069.
2020
Mapping global variation in dengue transmission intensity
Science Translational Medicine.
12(528)
[DOI] 10.1126/scitranslmed.aax4144.
2020
The use of mobile phone data to inform analysis of COVID-19 pandemic epidemiology
Nature Communications.
11(1)
[DOI] 10.1038/s41467-020-18190-5.
[PMID] 32999287.
2019
An open challenge to advance probabilistic forecasting for dengue epidemics
Proceedings of the National Academy of Sciences.
116(48):24268-24274
[DOI] 10.1073/pnas.1909865116.
[PMID] 31712420.
2019
Differential mobility and local variation in infection attack rate
PLOS Computational Biology.
15(1)
[DOI] 10.1371/journal.pcbi.1006600.
[PMID] 30668575.
2019
Impact of preexisting dengue immunity on Zika virus emergence in a dengue endemic region
Science.
363(6427):607-610
[DOI] 10.1126/science.aav6618.
[PMID] 30733412.
2019
Impacts of Zika emergence in Latin America on endemic dengue transmission
Nature Communications.
10(1)
[DOI] 10.1038/s41467-019-13628-x.
[PMID] 31844054.
2019
N95 Respirators vs Medical Masks for Preventing Influenza Among Health Care Personnel: A Randomized Clinical Trial.
JAMA.
322(9):824-833
[DOI] 10.1001/jama.2019.11645.
[PMID] 31479137.
2018
Prospective forecasts of annual dengue hemorrhagic fever incidence in Thailand, 2010–2014
Proceedings of the National Academy of Sciences.
115(10)
[DOI] 10.1073/pnas.1714457115.
[PMID] 29463757.
2017
Dengue diversity across spatial and temporal scales: Local structure and the effect of host population size
Science.
355(6331):1302-1306
[DOI] 10.1126/science.aaj9384.
[PMID] 28336667.
2017
Immune status alters the probability of apparent illness due to dengue virus infection: Evidence from a pooled analysis across multiple cohort and cluster studies
PLOS Neglected Tropical Diseases.
11(9)
[DOI] 10.1371/journal.pntd.0005926.
[PMID] 28953902.
2016
The impact of rainfall and temperature on the spatial progression of cases during the chikungunya re-emergence in Thailand in 2008-2009.
Transactions of the Royal Society of Tropical Medicine and Hygiene.
110(2):125-33
[DOI] 10.1093/trstmh/trv114.
[PMID] 26822605.
2016
The Long-Term Safety, Public Health Impact, and Cost-Effectiveness of Routine Vaccination with a Recombinant, Live-Attenuated Dengue Vaccine (Dengvaxia): A Model Comparison Study
PLOS Medicine.
13(11)
[DOI] 10.1371/journal.pmed.1002181.
[PMID] 27898668.
Grants
Dec 2023
ACTIVE
Tick Bite Biomarker Study: Evaluating exposure to tick bites by measuring antibodies in humans against a tick saliva biomarker in retrospective and prospective cohorts
Role: Principal Investigator
Funding: PFIZER INC
Aug 2023
ACTIVE
Identification of serological markers of protection and risk for dengue vaccines and natural infection
Role: Principal Investigator
Funding: NATL INST OF HLTH NIAID
Jul 2022
ACTIVE
CDC Southeastern Center of Excellence in Vector-Borne Diseases: Gateway Program
Role: Co-Project Director/Principal Investigator
Funding: CTRS FOR DISEASE CONTROL AND PREVENTION
Apr 2022
– Mar 2024
RAPID: Statistical inference of incidence of SARS-CoV-2 in the US using multiple data streams to identify levels of immunity and the impact of non-pharmaceutical interventions
Role: Principal Investigator
Funding: NATL SCIENCE FOU
Mar 2022
– Dec 2023
Estimating the incidence of dengue in travelers from non-endemic countries
Role: Principal Investigator
Funding: Merck Sharp & Dohme
Jun 2021
ACTIVE
Cross-reactivity of SARS-CoV-2 with coronaviruses isolated from humans in Haiti
Role: Co-Investigator
Funding: NATL INST OF HLTH NIAID
Apr 2021
ACTIVE
Human mobility models to forecast disease dynamics and the effectiveness of public health interventions
Role: Principal Investigator
Funding: JOHNS HOPKINS BLOOMBERG SCHOOL PUB HLTH
via NATL INST OF HLTH NIAID
Sep 2020
– Aug 2021
Statistician Support for the Respiratory Protection Effectiveness Clinical Trial
Role: Principal Investigator
Funding: CTRS FOR DISEASE CONTROL AND PREVENTION
Aug 2020
– Mar 2022
Support to Epicentre on Ebola research in DRC
Role: Principal Investigator
Funding: EPICENTRE
via LONDON SCHOOL OF HYGIENE & TROPICAL MED
Apr 2020
– Oct 2020
Statistical inference for intervention effects against SARS-CoV-2 in the counties of the United States
Role: Principal Investigator
Funding: JOHNS HOPKINS UNIVERSITY
via US FED EMERGENCY MGMT AGCY
Mar 2020
– Feb 2022
Integrating human mobility and pathogen genomics to understand dengue spatial dynamics
Role: Principal Investigator
Funding: JOHNS HOPKINS UNIVERSITY
via NATL INST OF HLTH NIAID
Feb 2020
ACTIVE
VTEU 17-0111 Tasks B-D
Role: Principal Investigator
Funding: EMORY UNIV
via NATL INST OF HLTH NIAID
Jun 2019
– Jun 2020
Statistician Support for the Respiratory Protection Effectiveness Clinical Trial (ResPECT)
Role: Principal Investigator
Funding: CTRS FOR DISEASE CONTROL AND PREVENTION
Aug 2018
– Dec 2023
Flavivirus Infections: Pathogenesis and Prevention
Role: Principal Investigator
Funding: UNIV OF RHODE ISLAND
via NATL INST OF HLTH NIAID
Apr 2018
– Apr 2019
Statistician Support for the Respiratory Protection Effectiveness Clinical Trial (ResPECT)
Role: Principal Investigator
Funding: CTRS FOR DIS CNTRL INST OCCUP SFTY HLTH
Dec 2017
– Jan 2020
RESpect
Role: Principal Investigator
Funding: UNIV OF TEXAS SW MEDICAL CENTER
via ASST SEC FOR PREPAREDNESS AND RESPONSE
Sep 2017
– Jul 2019
Assess the impact of patient and contextual factors on the incidence of S. aureus infections among target patients with the goal of identifying patient subgroups, which bear a disproportionate burden of S. aureus healthcare-associated infections (HAI)
Role: Principal Investigator
Funding: JOHNS HOPKINS UNIVERSITY
via MEDIMMUNE
Aug 2017
– Jan 2021
Identification of potent cross neutralizing Dengue antibodies using single-cell technology
Role: Co-Investigator
Funding: NATL INST OF HLTH NIAID
Dec 2016
– Jun 2022
Southeastern Regional CoE in Vector-Borne Diseases: The Gateway Program
Role: Co-Investigator
Funding: CTRS FOR DISEASE CONTROL AND PREVENTION
Jul 2016
– Jun 2019
Modeling interactions between HIV interventions in key populations in India
Role: Principal Investigator
Funding: NATL INST OF HLTH NIAID
Jul 2016
– Jan 2019
Methods for Reducing Spatial Uncertainty and Bias in Disease Surveillance
Role: Principal Investigator
Funding: JOHNS HOPKINS UNIVERSITY
via NATL INST OF HLTH NIAID
Jul 2016
– Aug 2017
Monitoring cause-specific school absences to estimate influenza transmission in Western PA
Role: Principal Investigator
Funding: CTRS FOR DISEASE CONTROL AND PREVENTION
May 2016
– Oct 2017
Influenza Immunity and Survival in Aging Populations
Role: Principal Investigator
Funding: JOHNS HOPKINS BLOOMBERG SCHOOL PUB HLTH
via NATL INST OF HLTH NIA
May 2016
– Oct 2017
RAPID: Data Driven Mathematical Modeling of the Shared Epidemiology of Zika and Other Arboviruses Across the Globe
Role: Principal Investigator
Funding: NATL SCIENCE FOU
Sep 2015
– Jan 2022
LINKING ANTIGENIC & GENETIC VARIATION OF DENGUE TOINDIVIDUAL AND POPULATION RISK
Role: Principal Investigator
Funding: NATL INST OF HLTH NIAID
Sep 2015
– Jun 2019
Computational Models of Infectious Disease Threats
Role: Principal Investigator
Funding: UNIV OF PITTSBURGH
via NATL INST OF HLTH NIGMS
Sep 2015
– Nov 2016
Inference for interacting pathogens with mechanistic and phenomenological models
Role: Principal Investigator
Funding: UNIV OF MASSACHUSETTS AMHERST
via NATL INST OF HLTH
Contact Details
Phones:
- Business:
- (352) 392-1107
Emails:
- Business:
- datc@ufl.edu
Addresses:
- Business Mailing:
-
PO BOX 118525
DEPARTMENT OF BIOLOGY
GAINESVILLE FL 326118525 - Business Street:
-
PO Box 118525
GAINESVILLE FL 32611